tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Immunome initiated with a Buy at Craig-Hallum
PremiumThe FlyImmunome initiated with a Buy at Craig-Hallum
1M ago
Immunome’s Varegacestat: Promising Phase 3 Prospects and Competitive Edge in Desmoid Tumor Treatment
Premium
Ratings
Immunome’s Varegacestat: Promising Phase 3 Prospects and Competitive Edge in Desmoid Tumor Treatment
1M ago
Gap downgraded, Ulta upgraded: Wall Street’s top analyst calls
Premium
The Fly
Gap downgraded, Ulta upgraded: Wall Street’s top analyst calls
2M ago
Immunome’s Promising Clinical Progress and Strong Financial Position Justify Buy Rating
PremiumRatingsImmunome’s Promising Clinical Progress and Strong Financial Position Justify Buy Rating
2M ago
Immunome reports Q2 EPS (50c), consensus (50c)
Premium
The Fly
Immunome reports Q2 EPS (50c), consensus (50c)
2M ago
Immunome Elects New Directors at Annual Meeting
Premium
Company Announcements
Immunome Elects New Directors at Annual Meeting
4M ago
Immunome reports Q1 EPS (52c), consensus (57c)
PremiumThe FlyImmunome reports Q1 EPS (52c), consensus (57c)
5M ago
Piper says SpringWorks deal suggests Immunome’s varegacestat ‘undervalued’
Premium
The Fly
Piper says SpringWorks deal suggests Immunome’s varegacestat ‘undervalued’
5M ago
Immunome initiated with a Buy at Lake Street
Premium
The Fly
Immunome initiated with a Buy at Lake Street
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100